153 related articles for article (PubMed ID: 38328983)
21. Chondroid tenosynovial giant cell tumor: a clinicopathological and immunohistochemical analysis of 5 new cases.
Hoch BL; Garcia RA; Smalberger GJ
Int J Surg Pathol; 2011 Apr; 19(2):180-7. PubMed ID: 21087985
[TBL] [Abstract][Full Text] [Related]
22. From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses.
Mok Y; Lee JC; Lum JH; Petersson F
Histopathology; 2016 May; 68(6):925-30. PubMed ID: 26407099
[TBL] [Abstract][Full Text] [Related]
23. EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literature.
Cohen JN; Sabnis AJ; Krings G; Cho SJ; Horvai AE; Davis JL
Hum Pathol; 2018 Nov; 81():281-290. PubMed ID: 29626598
[TBL] [Abstract][Full Text] [Related]
24. ZFTA::RELA fusion in a distinct liposarcoma morphologically overlapping with chondroid lipoma.
Sumida S; Toki SI; Mori T; Satomi K; Takao S; Nobusawa S; Kakimoto T; Nakagawa S; Ryo E; Matsushita Y; Ichimura K; Nishisho T; Bando Y; Yoshida A
Genes Chromosomes Cancer; 2023 Feb; 62(2):101-106. PubMed ID: 36201637
[TBL] [Abstract][Full Text] [Related]
25. Epithelioid Soft Tissue Neoplasm of the Soft Palate with a PTCH1-GLI1 Fusion: A Case Report and Review of the Literature.
Klubíčková N; Kinkor Z; Michal M; Baněčková M; Hájková V; Michálek J; Pink R; Dvořák Z; Michal M; Leivo I; Skálová A
Head Neck Pathol; 2022 Jun; 16(2):621-630. PubMed ID: 34655412
[TBL] [Abstract][Full Text] [Related]
26. Chondroid lipoma associated with osteoclast-like multinucleated giant cells - a case report.
Alyousef M; Al Nemer A
APMIS; 2017 May; 125(5):506-508. PubMed ID: 28370619
[TBL] [Abstract][Full Text] [Related]
27. Fine needle aspiration biopsy of epithelioid-mesenchymal neoplasm with PTCH1-GLI1 fusion: A case report.
Shahabi A; Israel AK; Sullivan CB; McHugh KE
Diagn Cytopathol; 2022 Aug; 50(8):E223-E229. PubMed ID: 35514197
[TBL] [Abstract][Full Text] [Related]
28. Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease.
Spiegelberg C; Giedl J; Gaisa NT; Rogler A; Riener MO; Filbeck T; Burger M; Ruemmele P; Hartmann A; Stoehr R
Int J Clin Exp Pathol; 2014; 7(4):1708-13. PubMed ID: 24817968
[TBL] [Abstract][Full Text] [Related]
29. RREB1::MRTFB fusion-positive extra-glossal mesenchymal neoplasms: A series of five cases expanding their anatomic distribution and highlighting significant morphological and phenotypic diversity.
Agaimy A; Din NU; Dermawan JK; Haller F; Melzer K; Denz A; Baumhoer D; Stoehr R; Grützmann R; Antonescu CR
Genes Chromosomes Cancer; 2023 Jan; 62(1):5-16. PubMed ID: 35763541
[TBL] [Abstract][Full Text] [Related]
30. Acral FibroChondroMyxoid tumor: imaging features of a new entity.
Le Corroller T; Macagno N; Nihous H; Champsaur P; Bouvier C
Skeletal Radiol; 2021 Mar; 50(3):603-607. PubMed ID: 32844242
[TBL] [Abstract][Full Text] [Related]
31. Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features.
Salah HT; D'ardis JA; Baek D; Schwartz MR; Ayala AG; Ro JY
Ann Diagn Pathol; 2022 Jun; 58():151937. PubMed ID: 35344860
[TBL] [Abstract][Full Text] [Related]
32. Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas.
Pu X; Ye Q; Cai J; Yang X; Fu Y; Fan X; Wu H; Chen J; Qiu Y; Yue S
Cell Death Dis; 2021 Mar; 12(3):256. PubMed ID: 33692336
[TBL] [Abstract][Full Text] [Related]
33. Pleomorphic angiomatoid fibrous histiocytoma: a case confirmed by fluorescence in situ hybridization analysis for EWSR1 rearrangement.
Weinreb I; Rubin BP; Goldblum JR
J Cutan Pathol; 2008 Sep; 35(9):855-60. PubMed ID: 18422688
[TBL] [Abstract][Full Text] [Related]
34. Primary Cutaneous Epithelioid Mesenchymal Tumor With a Novel ATP2B4::GLI1 Gene Fusion.
Rezaee N; Cohen B; Eno C; Shon W
Am J Dermatopathol; 2023 Sep; 45(9):642-645. PubMed ID: 37506273
[TBL] [Abstract][Full Text] [Related]
35. Polyclonal Secondary
Goyal L; Saha SK; Liu LY; Siravegna G; Leshchiner I; Ahronian LG; Lennerz JK; Vu P; Deshpande V; Kambadakone A; Mussolin B; Reyes S; Henderson L; Sun JE; Van Seventer EE; Gurski JM; Baltschukat S; Schacher-Engstler B; Barys L; Stamm C; Furet P; Ryan DP; Stone JR; Iafrate AJ; Getz G; Porta DG; Tiedt R; Bardelli A; Juric D; Corcoran RB; Bardeesy N; Zhu AX
Cancer Discov; 2017 Mar; 7(3):252-263. PubMed ID: 28034880
[TBL] [Abstract][Full Text] [Related]
36. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
37. Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications.
Lee CH; Su SY; Sittampalam K; Chen PC; Petersson F; Kao YC; Carpenter TO; Hsieh TH; Konishi E; Tsai JW; Billings SD; Folpe AL; Lee JC
Mod Pathol; 2020 May; 33(5):858-870. PubMed ID: 31792355
[TBL] [Abstract][Full Text] [Related]
38. Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity.
Dermawan JK; DiNapoli SE; Sukhadia P; Mullaney KA; Gladdy R; Healey JH; Agaimy A; Cleven AH; Suurmeijer AJH; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2023 Apr; 62(4):191-201. PubMed ID: 36344258
[TBL] [Abstract][Full Text] [Related]
39. The Co-mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion-Driven Cholangiocarcinoma.
Kendre G; Marhenke S; Lorz G; Becker D; Reineke-Plaaß T; Poth T; Murugesan K; Kühnel F; Woller N; Wirtz RM; Pich A; Marquardt JU; Saborowski M; Vogel A; Saborowski A
Hepatology; 2021 Sep; 74(3):1357-1370. PubMed ID: 33709535
[TBL] [Abstract][Full Text] [Related]
40. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
